Daniel Higbee
Impact in
- Infectious Diseases top 1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Ophthalmology top 5%
- Retinal Diseases and Treatments
Papers in
-
- Retinal Diseases and Treatments 6
-
- COVID-19 Clinical Research Studies 8
- Co-authors
- Zsolt Ablonczy (6 shared papers)Yiannis Koutalos (6 shared papers)Rosalie K. Crouch (6 shared papers)Raquel Granell (4 shared papers)James William Dodd (5 shared papers)Kevin L. Schey (3 shared papers)Angus C. Grey (2 shared papers)George Davey Smith (3 shared papers)
- Journals
- The Lancet (6 papers)European Respiratory Journal (4 papers)Investigative Ophthalmology & Visual Science (3 papers)ERJ Open Research (1 paper)Cytopathology (1 paper)
- Partner nations
- United KingdomUnited StatesNew Zealand
In The Last Decade
Daniel Higbee
23 papers receiving 2.2k citations
Daniel Higbee's Hit Papers
Peers
Comparison fields: 5 of 100
- Infectious Diseases 1.3k
- Ophthalmology 209
- Applied Microbiology and Biotechnology 35
- Pulmonary and Respiratory Medicine 323
- Internal Medicine 31
Countries citing papers authored by Daniel Higbee
This map shows the geographic impact of Daniel Higbee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Higbee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Higbee more than expected).
Fields of papers citing papers by Daniel Higbee
This network shows the impact of papers produced by Daniel Higbee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Higbee. The network helps show where Daniel Higbee may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Higbee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 411 |
| 2 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 393 |
| 3 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 4 | Effect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19 Hit paper breakdown → | 2022 | 252 |
| 5 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 231 |
| 6 | 2021 | 213 | |
| 7 | 2013 | 136 | |
| 8 | 2012 | 120 | |
| 9 | Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2023 | 84 |
| 10 | 2021 | 59 | |
| 11 | 2013 | 34 | |
| 12 | 2021 | 21 | |
| 13 | 2020 | 16 | |
| 14 | 2021 | 16 | |
| 15 | 2021 | 14 | |
| 16 | 2023 | 14 | |
| 17 | 2012 | 13 | |
| 18 | 2019 | 5 | |
| 19 | 2020 | 5 | |
| 20 | 2025 | 5 |
About Daniel Higbee
Daniel Higbee is a scholar working on Ophthalmology, Infectious Diseases, Pulmonary and Respiratory Medicine, Genetics and Physiology, having authored 24 papers that have together received 2.3k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (8 papers), Retinal Diseases and Treatments (6 papers), Genetic Associations and Epidemiology (4 papers), Retinal Development and Disorders (4 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers), Asthma and respiratory diseases (3 papers), Dementia and Cognitive Impairment Research (2 papers) and COVID-19 and Mental Health (1 paper). The work is most often cited by research in Infectious Diseases (1.3k citations), Ophthalmology (209 citations), Applied Microbiology and Biotechnology (35 citations), Pulmonary and Respiratory Medicine (323 citations) and Internal Medicine (31 citations). Daniel Higbee has collaborated with scholars based in United Kingdom, United States and New Zealand. Frequent co-authors include Zsolt Ablonczy, Yiannis Koutalos, Rosalie K. Crouch, Raquel Granell, James William Dodd, Kevin L. Schey, Angus C. Grey, George Davey Smith, Nicholas P. Boyer and Chunhe Chen. Their work appears in journals such as The Lancet, European Respiratory Journal, Investigative Ophthalmology & Visual Science, ERJ Open Research and Cytopathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.